Pentwater Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-395,000
Closed -$70M 187
2020
Q1
$70M Sell
395,000
-20,000
-5% -$3.77M 1.16% 26
2019
Q4
$79.3M Buy
415,000
+150,000
+57% +$27.1M 1.3% 18
2019
Q3
$44.6M Buy
265,000
+245,000
+1,225% +$39.9M 0.7% 27
2019
Q2
$3.35M Buy
+20,000
New +$2.77M 0.04% 101
2017
Q1
Sell
-185,000
Closed -$38.9M 128
2016
Q4
$38.9M Sell
185,000
-527,000
-74% -$109M 0.5% 36
2016
Q3
$164M Sell
712,000
-50,000
-7% -$12.2M 1.52% 13
2016
Q2
$176M Sell
762,000
-3,168,000
-81% -$730M 2.35% 12
2016
Q1
$1.05B Sell
3,930,000
-466,000
-11% -$133M 7.74% 3
2015
Q4
$1.37B Buy
4,396,000
+4,360,000
+12,111% +$1.3B 9.42% 2
2015
Q3
$9.79M Hold
36,000
0.09% 76
2015
Q2
$10.9M Sell
36,000
-594,000
-94% -$177M 0.06% 95
2015
Q1
$188M Buy
+630,000
New +$180M 1.4% 18

Other funds holding AGN

Pentwater Capital Management's AGN Position: Q2 2020 in Review

Pentwater Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,694,042 shares — an estimated $300M sold.

Pentwater Capital Management first reported a position in AGN in Q3 2014 and held it in 22 quarters. The position peaked at $1.35B in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Pentwater Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Pentwater Capital Management sold 1,694,042 Allergan plc shares in Q2 2020, an estimated $300M.
  • Pentwater Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 22 quarters.
  • Pentwater Capital Management's Allergan plc position peaked at $1.35B in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Pentwater Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.